Datasets:
ESGBERT
/
social_data

Dataset card Data Studio Files
xet
 Community
sentence
stringlengths
22
12k
This research has helped us better understand the experiences, unmet needs, and career tensions of our employees, especially women and minorities, and informed companywide D&I programs.
From the end of the number of women in management globally to 42 percent, our initial aspirational goal.
This year, we set even higher aspirational goals for women and minorities in management.
Core to our purpose is our commitment to aid human suffering—independent of an individual’s or nation’s economic status—and to conduct our business in a responsible way for the long term.
Lilly has set a goal to create new access to quality health care in resourcelimited settings for 2030.
It focuses on three areas: health systems; 2) Programs—enhancing access to Lilly medicines; and 3) Pipeline—finding molecules for diseases that disproportionately affect people in resource-limited settings.
In health programs, we gathered with local partners to launch a program addressing health disparities in our own hometown of Indianapolis.
The $community healthcare workers who help identify people with diabetes and connect them with quality care.
We do this through giving, volunteering, and focusing on the issues that tie back to our business: health and education.
Working on health and community projects across Africa, Asia, Europe, and Latin America, volunteers return to Lilly with insights that help us become a better, more globally aware company.
| P A G E The Lilly Foundation works to improve the lives of those who lack resources, including supporting and championing efforts in our home state of Indiana to strengthen public education focusing on early childhood education, K-12, and STEM subjects (science, technology, engineering, and math).
In September an initial public offering (IPO) of Elanco Animal Health Incorporated (NYSE: ELAN), thereby making it an independently traded company.
Elanco, previously a division of Lilly, is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets.
A G E Lilly has a longstanding commitment to bioethics—which focuses on the ethics of health care, biomedical research, and biomedical public policy—as an integral component of corporate integrity in the pharmaceutical industry.
A G E Protecting Research Subjects’ Rights in Clinical Trials Lilly is committed to protecting the rights and well-being of research subjects and patients who use our medicines.
Lilly’s Bioethics Framework for Human Biomedical Research provides a bioethics foundation for the company’s biomedical research so that it is aligned with broadly accepted ethics principles and Lilly’s core values.
Lilly’s Global Patient Safety organization— consisting of more than nurses, and other healthcare professionals—is dedicated to the continuous collection, monitoring, evaluation, and reporting of safety information.
A G E At Lilly, our efforts to ensure the safety and integrity of our products begin with the procurement of materials and extend throughout the production process.
This includes our interactions to promote strong health, safety, and environment (HSE) practices with suppliers who provide us materials for research and development, as well as with the contract manufacturers who help make our medicines and other pharmaceutical products.
AND IN THE FIELD Patient safety is the foundation of Lilly’s global anticounterfeiting efforts, and we are engaged in efforts to combat counterfeiters.
We are a founder and member of the Alliance for Safe Online Pharmacies, a global coalition of stakeholders with an interest in protecting patient safety and ensuring patients have access to safe and legitimate online pharmacies.
Lilly continues to work to expand access to medicines in the U.S. healthcare system—by helping consumers, communities, and our employees; by providing greater transparency about how our products are priced; and through the policies we promote.
AFTER DISCOUNTS ACROSS THE U.S. PRODUCT PORTFOLIO 20182017201620152014 59% 55% 50% 49% 46% deliver greater economic and health value to healthcare systems.
We are committed to finding solutions to lower out-of-pocket costs and to implement other changes that can help the U.S. health system work better for patients.
REDUCING COSTS AND IMPROVING HEALTH FOR EMPLOYEES AT LILLY Employers can play a key role in patient access and affordability by offering benefits that help reduce employee medical costs.
We exempt preventive and chronic disease medications from the deductible of our employees’ health plans to ensure there are no barriers for accessing medicines critical to their overall health and well-being.
Starting in eligible employees and their family members living with diabetes a free connected glucose meter and related supplies, along with real-time support from trained diabetes educators.
Out-ofpocket costs for people who use traditional co-pay or co-insurance plans will continue to be set by their health insurer, and federal regulations prevent people who use Medicare Part D or other federal programs from obtaining additional point-of-sale savings.
A G E Lilly 30x30 To accelerate our global health efforts, we established Lilly 30x30—a bold goal to increase access to quality health care in communities with limited resources for 30 million people on an annual basis by 2030.
As a leading biopharmaceutical company, Lilly has an important role to play in improving access to quality health care for people living in communities with limited resources.
Our global health efforts focus on people who aren’t typically reached by our traditional business operations.
A G E Partnerships Through strategic partnerships providing support and funding, Lilly and the Eli Lilly and Company Foundation, a separate, independent, nonprofit organization, work to advance government priorities, strengthen local healthcare systems, and improve access to care.
Lilly uses its technology and expertise in collaborations with other organizations to find innovative, sustainable, and scalable approaches and solutions to pressing global health concerns, including diabetes and cancer.
GLOBAL HEALTH PARTNERSHIP The Lilly Global Health Partnership advances more than improve access and care.
Under new leadership and with increased strategic focus in on developing collaborations with a variety of partners to expand access to quality care for people living in resource-limited settings.
Lilly Global Health Partnership Focus Areas Working with expert partners, the Lilly Global Health Partnership helps people living in limited-resource settings, with a focus on five countries.
G O A L S Lilly partners with local institutions around the world to pilot and extend the reach of effective health programs.
We also advocate for the increased prioritization of non-communicable diseases (NCDs)—including cardiovascular diseases, cancer, diabetes, and mental health conditions—on the health agenda at the global and national levels.
Lilly is also a member of the NCD Alliance, a global thought leader that brings the voice of communities and civil society to policy and practice related to NCDs.
For more than providing support and funding to help AMPATH provide medicines and quality health care to people living in western Kenya.
AMPATH, which stands for Academic Model Providing Access to Healthcare, was created in epidemic in western Kenya.
Today, AMPATH serves a population of more than sites—from village health centers and dispensaries, to county hospitals, to the Moi Teaching and Referral Hospital in Eldoret, where the organization is headquartered.
To date, AMPATH has trained professional and community health workers, building local knowledge and service capacity.
To help address this gap, the Lilly Foundation committed an additional $cervical cancer screenings.
Lilly also sends employees to volunteer with AMPATH through the company’s Connecting Hearts Abroad program.
Within the health system, AMPATH and Lilly have worked with the Kenyan government to develop innovative solutions to improve the overall donation process, minimize delays, and improve the availability of muchneeded medicines.
Nancy received early diagnosis and treatment for breast cancer thanks to community health screenings through AMPATH, Lilly’s global health partner in Kenya.
THE LESSONS BACK HOME TO INDIANA In the spring of organizations to launch a new pilot program with the goal of using community outreach to combat type 2 diabetes in three of the city’s most at-risk neighborhoods.
The lower life expectancy rate is largely due to health disparities and is similar to rates seen in countries such as Iraq and Bangladesh.
The pilot is powered by newly-hired community healthcare workers to help identify people with diabetes and connect them with quality care.
In addition, community members will help identify and propose solutions for the cultural, social, environmental, economic, and policy barriers that increase the risk for diabetes, such as the lack of healthy food options and public spaces for exercise.
The pilot uses Lilly’s global health framework, which includes studying key research questions, reporting what works and what doesn’t, and then using the data to advocate for the scale-up of the most effective solutions.
The program will contribute to Lilly goal to create new access to quality health care for 30 million people in underserved communities on an annual basis by 2030.
Lilly and its partners are testing the hypothesis that the implementation of a multi-pronged community health model will reduce complications for those with diabetes and reduce risk factors for those considered at high risk for developing the disease.
The program currently provides access to care, education, and life-saving medicines and supplies to nearly diabetes in 42 developing countries.
The program has also established new evidence regarding the outcomes for children affected by type less-resourced countries and, in some countries, has helped catalyze national awareness and policy change that has helped make the disease a government priority.
In more than 120,000 people in the United States obtain the Lilly medications they needed in the areas of mental health, diabetes, cardiovascular disease, men’s health, osteoporosis, arthritis, cancer, psoriasis, migraine, and growth hormone disorders.
Through this effort, we are applying what we’ve learned from our global health work in underserved communities around the world with the expertise of our local partners and the passion of the people living in these neighborhoods.
A G E Partnering with Project Hope in Puerto Rico In the wake of the devastation that followed Hurricane Maria in 2017, much of Puerto Rico—where Lilly has two manufacturing facilities—continued to struggle in 2018 with infrastructure challenges, such as spotty electricity and disrupted access to medical care and healt...
In the face of these challenges, we maintained our commitment to helping Puerto Rico recover, sending two teams of medical professionals to the island—including nurses and diabetes educators—to volunteer.
The specialized skills-based volunteer program allowed Lilly physicians, scientists, and other healthcare professionals to apply their expertise and passion to directly impact people with, or at risk for, diabetes in communities outside of the San Juan and Ponce metropolitan areas, both heavily affected by the hurrican...
Outreach services are critical in the posthurricane context, as the storm significantly disrupted access to many healthcare services and referral networks.
When it struck, Hurricane Maria exposed preexisting challenges in Puerto Rico—and created new ones—further limiting access to quality healthcare services, medications, healthy food, and clean drinking water in an already overburdened public sector.
For those on the island living with diabetes, or at risk for the disease, the effects of Hurricane Maria have complicated their ability to get access to adequate care and treatment, as well as vital self-management programs.
Although maintaining a healthy diet is a critical component of successfully managing diabetes, as well as hypertension, many in Puerto Rico are routinely without access to fresh fruits and vegetables.
Lilly volunteers conducted diabetes screenings and testing, health education, and treatment support.
They also helped train local healthcare providers and provided support for a community garden initiative to help ensure families have access to healthy food options.
R I C O EMPLOYEE VOLUNTEERS HOURS SERVED Programs Through Lilly 30x30, we are strengthening existing programs and developing new approaches that help people in resource-limited settings get greater access to Lilly products and services.
These efforts include exploring and expanding alternative business models that create shared value for society and Lilly, pricing strategies, patient support programs, and product donations.
In an effort to expand access to our medicines, Lilly designs and supports programs that take into consideration a patient’s income level and ability to pay.
To solve some of the toughest challenges in medicine, we need the most innovative ideas from the best talent in the world.
Our company’s values—integrity, excellence, and respect for people—shape our approach to attracting and developing a highly skilled and ethical workforce.
We are committed to fairness and nondiscrimination in our employment practices, and we value diverse backgrounds, skills, and global perspectives.
In this section, we discuss our efforts to provide employees with a safe, supportive, and rewarding work environment, and to offer fair compensation, training, and career development.
Not only do we want to inspire our employees and attract the best talent, we want those who do business with Lilly to find us trustworthy and easy to work with.
In standards and procedures to include specific language about human rights, including our expectation that vendors to Lilly abide by Lilly’s human rights standards as one piece of our Supplier Code of Conduct.
, we support a culture of well-being by providing competitive pay, comprehensive employee benefit programs, training and development resources, and opportunities for employees to serve in their communities and around the world.
Lilly is committed to ensuring pay equity for all of our employees.
These may include flexible work arrangements; on-site conveniences, such as cafes, fitness centers, and child care; competitive timeoff programs; retirement benefits; and health and disability programs that are available to eligible employees when they need support.
Read more in our Employee Well-Being at Lilly section.
At Lilly, employee safety and well-being are managed by our Health, Safety, and Environment (HSE) team.
We also provide training about corporate policies, such as those contained in our code of conduct.
And we work to cultivate a culture of lifelong learning by encouraging employees to seek ongoing education and growth experiences, helping them to build careers that are rewarding both personally and professionally.
To help individuals navigate these opportunities, we offer access to learning and development programs that can assist individuals looking to acquire the new skills needed to achieve career aspirations.
Embracing diversity at Lilly means understanding, respecting, and valuing differences, including race, religion, sexual orientation, gender identity, disability status, work style, national origin, and age.
This perspective helps us to attract and retain the best talent from around the world—people from all backgrounds, who can understand the perspectives of our diverse customers.
Our efforts to build a more diverse and inclusive workforce at Lilly have gained momentum since we began a research initiative to better understand the lived experiences of women and minorities at Lilly.
In recognition of this work, we recently won the recruitment, development, and advancement initiatives with a focus on proven, measurable results that benefit women across a range of dimensions—including race/ethnicity, sexual orientation, gender identity, religion, age, nationality, and disability.
This research revealed that cultural and gender differences were affecting the way some employees reported being seen and heard—or not.
Many women, for example, reported experiencing something called “imposter syndrome”—secretly feeling as though their qualifications weren’t enough.
Issues of authenticity were raised—where some minorities and women reported feeling pressure to act in ways that don’t reflect their own unique perspectives.
Women of color, especially, said they sometimes felt invisible.
To that end, in and 2018, we created and implemented a set of initiatives called the People Strategy to address what we found in our research, and to further embed D&I into our internal talent systems and processes.
women globally and minorities in the United States.
We’ve expanded training programs for leaders globally, to help them develop skills to support conscious inclusion and psychological safety.
We partner with advocacy groups, professional societies, community organizations, public and private healthcare administrators, and others to help reduce health disparities and to address the unique healthcare needs of all communities.
For example, some build plans that are related to gender, provincial, generational, and/or disability diversity.
They also assist with corporate executive training programs on topics such as cultural awareness and inclusion.
P A G E LGBTQ Employees at Lilly Lesbian, gay, bisexual, transgender, and queer (LGBTQ) people, and those with other sexual and gender identities, are an important segment of Lilly’s workforce.
In the United States, we are required to collect data on the race, gender, and ethnicity of our employees, as well as those who are military veterans or have disabilities— but there is no legal mandate for similar data collection on sexual orientation or gender identity.